GH-JPM-2026-Presentation.pdf

1、JP Morgan Healthcare ConferenceJanuary 12,20262Certain statements in this presentation and the accompanying oral commentary are forward-looking statements within the meaning of federal securities laws.These statements relate to future events or Guardant Health,Inc.(the“Company”)s future results and

2、involve known and unknown risks,uncertainties and other factors that may cause the actual results,levels of activity,performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements.In some cases,forward-looking s

3、tatements can be identified by terminology such as“may,”“will,”“could,”“would,”“should,”“to,”“target,”“expect,”“plan,”“anticipate,”“intend,”“believe,”“estimate,”“predict,”“potential”or other comparable terminology.All statements other than statements of historical fact could be deemed forward-lookin

4、g,including any expectations regarding the Companys commercial engine as a force multiplier for research and development initiatives;any projections of market opportunities;statements about the Companys ability to assess potential market opportunities or any statements about the Companys ability to

5、successfully develop new products and services;any statements regarding expectations for future reimbursement opportunities;any statements regarding the Companys long-term expectations,including with respect to oncology,liquid biopsy,and other aspects of the Companys industry;any statements about la

6、unching planned new products and additional laboratories,including with respect to Guardant Shield,CGP tissue assay,and laboratories outside the United States;any statements about the Companys ECLIPSE study;any statements regarding expectations for future regulatory approvals;any statements about hi